UNITY Biotechnology (UBX)
(Delayed Data from NSDQ)
$1.42 USD
+0.02 (1.43%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $1.40 -0.02 (-1.41%) 6:40 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | 29.55% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.49 |
Next Year | -1.71 |
EPS (TTM) | -1.85 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.24M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.42 | -1.49 | -1.71 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.40 | -0.42 | -1.49 | -1.71 |
High Estimate | -0.40 | -0.42 | -1.49 | -1.71 |
Low Estimate | -0.40 | -0.42 | -1.49 | -1.71 |
Year ago EPS | -0.67 | -0.53 | -2.74 | -1.49 |
Year over Year Growth Est. | 40.30% | 20.75% | 45.62% | -14.77% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.42 | -1.49 | -1.71 |
7 Days Ago | -0.40 | -0.42 | -1.49 | -1.71 |
30 Days Ago | -0.40 | -0.42 | -1.49 | -1.71 |
60 Days Ago | -0.40 | -0.42 | -1.49 | -1.71 |
90 Days Ago | -0.46 | -0.48 | -1.74 | -1.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.40 | -0.42 | -1.49 | -1.71 |
Zacks Consensus Estimate | -0.40 | -0.42 | -1.49 | -1.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.34 | -0.53 | -0.67 | NA |
Estimate | -0.44 | -0.57 | NA | -0.87 | NA |
Difference | 0.13 | 0.23 | NA | 0.20 | 0.19 |
Surprise | 29.55% | 40.35% | NA | 22.99% | 30.96% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more